Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne-Sophie W Møller

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Molecular Therapy Oncolytics|February 23, 2023
Next generation oncolytic viruses expressing PADI1 and TIMP2 exhibit anti-tumor activity against melanoma in nude and humanized mouse modelsLukasz Kuryk, Anne-Sophie W Møller
Journal of Medical Virology|January 17, 2020
Chimeric oncolytic Ad5/3 virus replicates and lyses ovarian cancer cells through desmoglein-2 cell entry receptorLukasz Kuryk, Anne-Sophie W Møller
Cancer Gene Therapy|July 31, 2018
Quantification and functional evaluation of CD40L production from the adenovirus vector ONCOS-401Lukasz Kuryk, Anne-Sophie W Møller, Magnus Jaderberg
Journal of Medical Virology|May 14, 2019
Abscopal effect when combining oncolytic adenovirus and checkpoint inhibitor in a humanized NOG mouse model of melanomaLukasz Kuryk, Anne-Sophie W Møller, Magnus Jaderberg
Oncoimmunology|February 5, 2019
Combination of immunogenic oncolytic adenovirus ONCOS-102 with anti-PD-1 pembrolizumab exhibits synergistic antitumor effect in humanized A2058 melanoma huNOG mouse modelLukasz Kuryk, Anne-Sophie W Møller, Magnus Jaderberg
The Journal of Infectious Diseases|February 3, 2005
Chemokine patterns in meningococcal diseaseAnne-Sophie W Møller, Anna Bjerre, Berit Brusletto, et al.
Journal of Medical Virology|May 26, 2018
Antitumor-specific T-cell responses induced by oncolytic adenovirus ONCOS-102 (AdV5/3-D24-GM-CSF) in peritoneal mesothelioma mouse modelLukasz Kuryk, Anne-Sophie W Møller, Mariangela Garofalo, et al.
International Journal of Molecular Sciences|February 3, 2019
Optimization of Early Steps in Oncolytic Adenovirus ONCOS-401 Production in T-175 and HYPERFlasksLukasz Kuryk, Anne-Sophie W Møller, Antti Vuolanto, et al.
Journal of Endotoxin Research|January 22, 2004
Effects of bacterial cell wall components (PAMPs) on the expression of monocyte chemoattractant protein-1 (MCP-1), macrophage inflammatory protein-1alpha (MIP-1alpha) and the chemokine receptor CCR2 by purified human blood monocytesAnne-Sophie W Møller, Reidun Øvstebø, Ase-Brit Westvik, et al.
Cytokine|January 13, 2006
Chemokine production and pattern recognition receptor (PRR) expression in whole blood stimulated with pathogen-associated molecular patterns (PAMPs)Anne-Sophie W Møller, Reidun Ovstebø, Kari Bente F Haug, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Molecular Therapy Oncolytics|February 23, 2023
Next generation oncolytic viruses expressing PADI1 and TIMP2 exhibit anti-tumor activity against melanoma in nude and humanized mouse modelsLukasz Kuryk, Anne-Sophie W Møller
Journal of Medical Virology|January 17, 2020
Chimeric oncolytic Ad5/3 virus replicates and lyses ovarian cancer cells through desmoglein-2 cell entry receptorLukasz Kuryk, Anne-Sophie W Møller
Cancer Gene Therapy|July 31, 2018
Quantification and functional evaluation of CD40L production from the adenovirus vector ONCOS-401Lukasz Kuryk, Anne-Sophie W Møller, Magnus Jaderberg
Journal of Medical Virology|May 14, 2019
Abscopal effect when combining oncolytic adenovirus and checkpoint inhibitor in a humanized NOG mouse model of melanomaLukasz Kuryk, Anne-Sophie W Møller, Magnus Jaderberg
Oncoimmunology|February 5, 2019
Combination of immunogenic oncolytic adenovirus ONCOS-102 with anti-PD-1 pembrolizumab exhibits synergistic antitumor effect in humanized A2058 melanoma huNOG mouse modelLukasz Kuryk, Anne-Sophie W Møller, Magnus Jaderberg
The Journal of Infectious Diseases|February 3, 2005
Chemokine patterns in meningococcal diseaseAnne-Sophie W Møller, Anna Bjerre, Berit Brusletto, et al.
Journal of Medical Virology|May 26, 2018
Antitumor-specific T-cell responses induced by oncolytic adenovirus ONCOS-102 (AdV5/3-D24-GM-CSF) in peritoneal mesothelioma mouse modelLukasz Kuryk, Anne-Sophie W Møller, Mariangela Garofalo, et al.
International Journal of Molecular Sciences|February 3, 2019
Optimization of Early Steps in Oncolytic Adenovirus ONCOS-401 Production in T-175 and HYPERFlasksLukasz Kuryk, Anne-Sophie W Møller, Antti Vuolanto, et al.
Journal of Endotoxin Research|January 22, 2004
Effects of bacterial cell wall components (PAMPs) on the expression of monocyte chemoattractant protein-1 (MCP-1), macrophage inflammatory protein-1alpha (MIP-1alpha) and the chemokine receptor CCR2 by purified human blood monocytesAnne-Sophie W Møller, Reidun Øvstebø, Ase-Brit Westvik, et al.
Cytokine|January 13, 2006
Chemokine production and pattern recognition receptor (PRR) expression in whole blood stimulated with pathogen-associated molecular patterns (PAMPs)Anne-Sophie W Møller, Reidun Ovstebø, Kari Bente F Haug, et al.
Pageof 2